. . . . . . . . . . . . . . . . "a(SCHEM:\"15-deoxy-D12,14-prostaglandin J2\") -| (a(SCHEM:\"Tetradecanoylphorbol acetate\") -> r(HGNC:MMP9))" . "a(SCHEM:\"Tetradecanoylphorbol acetate\") -> r(HGNC:MMP9)" . "Approximately 61,000 statements." . "Copyright (c) 2011-2012, Selventa. All rights reserved." . "BEL Framework Large Corpus Document" . . "20131211" . "Treatment of VSMCs with the PPARgamma ligands troglitazone and the naturally occurring 15-deoxy-Delta12, 14-prostaglandin J2 (15d-PGJ2) decreased phorbol 12-myristate 13-acetate-induced MMP-9 mRNA and protein levels, as well as MMP-9 gelatinolytic activity in the supernatants in a concentration-dependent manner. " . . "Selventa" . . . . "2014-07-03T14:34:18.922+02:00"^^ . . .